630JPY
23.80 BJPY
827.70 BJPY
18.83 M
About COSMOS PHARMACEUTICAL CORP
Sector
Industry
Headquarters
Fukuoka
Website
Employees (FY)
5.29 K
Founded
1973
ISIN
JP3298400007
FIGI
BBG000Q2PVC7
COSMOS Pharmaceutical Corp. engages in the operation of drugstores. It operates through the following business divisions: Pharmaceutical, Cosmetics, Miscellaneous Goods, General Food, and Others. The Pharmaceutical division markets general drugs, health drinks, oral and nursing care products, vitamins, health food, and dietary food and supplements. The Cosmetics division engages in the sale of skin and hair care products for men and women; and makeup kits. The Miscellaneous Goods division sells detergents, insecticides, toiletries, kitchenware, garden supplies, clothing, and car related products. The General Food division includes processed food, seasonings, bread, pastries, dairy products, beverages, and liquor. The Others division distributes tobacco and cigarettes. The company was founded by Masateru Uno and Noriko Uno in February 1973 and is headquartered in Fukuoka, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 3349 is 14555 JPY — it has decreased by 1.42% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange COSMOS PHARMACEUTICAL CORP stocks are traded under the ticker 3349.
COSMOS PHARMACEUTICAL CORP is going to release the next earnings report on Jul 8, 2024. Keep track of upcoming events with our Earnings Calendar.
3349 stock is 2.43% volatile and has beta coefficient of −0.13. Check out the list of the most volatile stocks — is COSMOS PHARMACEUTICAL CORP there?
One year price forecast for COSMOS PHARMACEUTICAL CORP has a max estimate of 20000 JPY and a min estimate of 13100 JPY.
3349 earnings for the last quarter are 128.18 JPY whereas the estimation was 123.40 JPY which accounts for 3.87% surprise. Estimated earnings for the next quarter are 135.51 JPY. See more details about COSMOS PHARMACEUTICAL CORP earnings.
COSMOS PHARMACEUTICAL CORP revenue for the last quarter amounts to 234.78 B JPY despite the estimated figure of 228.62 B JPY. In the next quarter revenue is expected to reach 235.28 B JPY.
Yes, you can track COSMOS PHARMACEUTICAL CORP financials in yearly and quarterly reports right on TradingView.
3349 stock has risen by 4.30% compared to the previous week, the month change is a 2.72% rise, over the last year COSMOS PHARMACEUTICAL CORP has showed a 14.79% increase.
3349 net income for the last quarter is 5.77 B JPY, while the quarter before that showed 5.08 B JPY of net income which accounts for 13.61% change. Track more COSMOS PHARMACEUTICAL CORP financial stats to get the full picture.
Today COSMOS PHARMACEUTICAL CORP has the market capitalization of 568.08 B, it has decreased by 0.83% over the last week.
COSMOS PHARMACEUTICAL CORP dividend yield was 0.75% in 2022, and payout ratio reached 16.64%. The year before the numbers were 0.66% and 13.68% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 3349 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade COSMOS PHARMACEUTICAL CORP stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 5.29 K employees. See our rating of the largest employees — is COSMOS PHARMACEUTICAL CORP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So COSMOS PHARMACEUTICAL CORP technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating COSMOS PHARMACEUTICAL CORP stock shows the buy signal. See more of COSMOS PHARMACEUTICAL CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on COSMOS PHARMACEUTICAL CORP future price: according to them, 3349 price has a max estimate of 20000.00 JPY and a min estimate of 13100.00 JPY. Read a more detailed COSMOS PHARMACEUTICAL CORP forecast: see what analysts think of COSMOS PHARMACEUTICAL CORP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. COSMOS PHARMACEUTICAL CORP EBITDA is 50.90 B JPY, and current EBITDA margin is 5.74%. See more stats in COSMOS PHARMACEUTICAL CORP financial statements.